Eurofins Scientific CEO-controlled Analytical Bioventures buys EUR 218,458 of shares

• Eurofins Scientific PDMR Analytical Bioventures S.C.A, controlled by CEO Dr. Gilles Martin, bought 3,000 shares on-market.
• Total consideration EUR 218,458 based on trade prices of EUR 73.69, EUR 73.15, EUR 71.62 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eurofins Scientific SE published the original content used to generate this news brief via Business Wire (Ref. ID: 202609081133BIZWIRE_USPR_____20260908_BW555498) on September 08, 2026, and is solely responsible for the information contained therein.